CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Humana Q3 adjusted loss narrows on Medicaid businesses, revenue slightly beats estimates

By Reuters News


Overview

  • U.S. health insurer's Q3 adjusted revenue slightly beat analyst expectations

  • Adjusted loss per share for Q3 was better than analyst estimates

  • Company raised full-year 2026 adjusted EPS guidance


Outlook

  • Humana raises FY 2026 adjusted EPS guidance to at least $9.50, up from $9.00

  • Company lifts FY 2026 GAAP EPS guidance to at least $15.09, up from $6.52

  • Humana expects FY 2026 adjusted EPS to decline year-on-year due to Star Ratings headwind


Result Drivers

  • CENTERWELL AND MEDICAID EXPANSION - Co said strategic expansion of CenterWell and Medicaid businesses contributed to results

  • CENTERWELL PATIENT GROWTH - Co reported 30% YTD growth in CenterWell Senior Primary Care patients

  • MEDICAID MEMBERSHIP - Co said Medicaid membership grew 7% YTD, driven by new integrated Duals programs


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Adjusted Revenue

Slight Beat*

$41.16 bln

$40.89 bln (17 Analysts)

Q3 Adjusted Loss Per Share

Beat

$0.70

$1.003 (25 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Reuters Recommended Reads

  • Nov 5 - Oscar Health beats Q3 revenue estimates, raises 2026 outlook

  • Nov 4 - Health insurers, hospitals rally after sweeping midterm win for Democrats

  • Nov 4 - Agilon Health Q3 revenue beats estimates, raises FY guidance


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.